These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24480356)

  • 1. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
    Lee JH; Seo SH; Lim EJ; Cho NC; Nam G; Kang SB; Pae AN; Jeong N; Keum G
    Eur J Med Chem; 2014 Mar; 74():246-57. PubMed ID: 24480356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
    Lee JE; Koh HY; Seo SH; Baek YY; Rhim H; Cho YS; Choo H; Pae AN
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4219-22. PubMed ID: 20621730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models.
    Lee MJ; Shin TJ; Lee JE; Choo H; Koh HY; Chung HJ; Pae AN; Lee SC; Kim HJ
    Pharmacol Biochem Behav; 2010 Dec; 97(2):198-204. PubMed ID: 20678515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.
    Kam YL; Rhee HK; Rhim H; Back SK; Na HS; Choo HY
    Bioorg Med Chem; 2010 Aug; 18(16):5938-44. PubMed ID: 20659804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
    Kim JH; Keum G; Chung H; Nam G
    Eur J Med Chem; 2016 Nov; 123():665-672. PubMed ID: 27517811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of pyrrolidine-based T-type calcium channel inhibitors for the treatment of neuropathic pain.
    Yang HK; Son WS; Lim KS; Kim GH; Lim EJ; Gadhe CG; Lee JY; Jeong KS; Lim SM; Pae AN
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1460-1471. PubMed ID: 30231778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
    Du Nguyen H; Okada T; Kitamura S; Yamaoka S; Horaguchi Y; Kasanami Y; Sekiguchi F; Tsubota M; Yoshida S; Nishikawa H; Kawabata A; Toyooka N
    Bioorg Med Chem; 2018 Aug; 26(15):4410-4427. PubMed ID: 30031654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH; Choi JK; Lee E; Lee JK; Rhim H; Seo SH; Kim Y; Doddareddy MR; Pae AN; Kang J; Roh EJ
    Bioorg Med Chem; 2007 Feb; 15(3):1409-19. PubMed ID: 17150365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain.
    M'Dahoma S; Gadotti VM; Zhang FX; Park B; Nam JH; Onnis V; Balboni G; Lee JY; Zamponi GW
    Pflugers Arch; 2016 Feb; 468(2):193-9. PubMed ID: 26354962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Benzamides and 3,4,5-trimethoxyphenyl amines as calcium channel blockers.
    Kang B; Oh JA; Lee JY; Rhim H; Yune TY; Park Choo HY
    Bioorg Med Chem; 2015 Sep; 23(18):6166-72. PubMed ID: 26296911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
    Son WS; Jeong KS; Lim SM; Pae AN
    Bioorg Med Chem Lett; 2019 May; 29(10):1168-1172. PubMed ID: 30928197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.